Cardiac involvement in the long-term implications of COVID-19

Benjamin A Satterfield1, Deepak L Bhatt2, Bernard J Gersh3

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Insights

Long COVID survivors may face lasting cardiovascular issues. New prospective studies are crucial now to understand and manage these long-term heart complications in post-COVID syndrome.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic has caused significant acute illness and death globally.
  • Vaccine advancements offer hope, shifting focus towards managing long-term health consequences.
  • Survivors of acute COVID-19 may experience persistent cardiovascular sequelae.

Purpose of the Study:

  • To review current knowledge on cardiovascular complications in COVID-19 survivors.
  • To identify critical research questions for understanding long-term cardiovascular effects.
  • To emphasize the need for immediate prospective studies on this population.

Main Methods:

  • This is a Perspectives article, synthesizing existing literature and expert opinion.
  • It highlights known cardiovascular sequelae based on current research.
  • It outlines future research directions and necessary methodologies.

Main Results:

  • Cardiovascular sequelae are a significant concern in COVID-19 survivors.
  • Specific long-term effects include myocarditis, arrhythmias, and thromboembolic events.
  • The full spectrum and mechanisms of these complications require further investigation.

Conclusions:

  • Prospective studies are urgently needed to monitor and understand cardiovascular health in COVID-19 survivors.
  • Research should focus on identifying risk factors and developing mitigation strategies for post-acute COVID-19 syndrome.
  • Adequate resources must be allocated to support long-term follow-up and research.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
64
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
73
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
71
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
31
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
65